MED19 polyclonal (C-term), anti-human

Background:
MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM].

Other Names:
Mediator of RNA polymerase II transcription subunit 19, Lung cancer metastasis-related protein 1, Mediator complex subunit 19, MED19, LCMR1

Target/Specificity:
This MED19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 161-188 amino acids from the C-terminal region of human MED19.

Antigen Region:
161-188

Antigen Type: Synthetic Peptide

Gene Name: MED19
Gene ID: 219541
Primary Accession: A0JLT2
NCBI Accession: NP_703151.1
Other Accession: Q8C1S0; NP_703151.1
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.